全文获取类型
收费全文 | 5565篇 |
免费 | 501篇 |
国内免费 | 48篇 |
专业分类
耳鼻咽喉 | 52篇 |
儿科学 | 262篇 |
妇产科学 | 137篇 |
基础医学 | 757篇 |
口腔科学 | 173篇 |
临床医学 | 693篇 |
内科学 | 1113篇 |
皮肤病学 | 87篇 |
神经病学 | 354篇 |
特种医学 | 265篇 |
外科学 | 827篇 |
综合类 | 112篇 |
一般理论 | 2篇 |
预防医学 | 601篇 |
眼科学 | 60篇 |
药学 | 309篇 |
1篇 | |
中国医学 | 11篇 |
肿瘤学 | 298篇 |
出版年
2022年 | 29篇 |
2021年 | 98篇 |
2020年 | 38篇 |
2019年 | 76篇 |
2018年 | 93篇 |
2017年 | 77篇 |
2016年 | 101篇 |
2015年 | 100篇 |
2014年 | 163篇 |
2013年 | 223篇 |
2012年 | 225篇 |
2011年 | 245篇 |
2010年 | 170篇 |
2009年 | 189篇 |
2008年 | 240篇 |
2007年 | 244篇 |
2006年 | 240篇 |
2005年 | 253篇 |
2004年 | 224篇 |
2003年 | 215篇 |
2002年 | 176篇 |
2001年 | 168篇 |
2000年 | 158篇 |
1999年 | 183篇 |
1998年 | 119篇 |
1997年 | 120篇 |
1996年 | 99篇 |
1995年 | 103篇 |
1994年 | 85篇 |
1993年 | 89篇 |
1992年 | 116篇 |
1991年 | 125篇 |
1990年 | 112篇 |
1989年 | 129篇 |
1988年 | 105篇 |
1987年 | 92篇 |
1986年 | 91篇 |
1985年 | 80篇 |
1984年 | 73篇 |
1983年 | 59篇 |
1982年 | 46篇 |
1981年 | 36篇 |
1980年 | 37篇 |
1979年 | 45篇 |
1978年 | 47篇 |
1977年 | 36篇 |
1976年 | 31篇 |
1974年 | 34篇 |
1973年 | 30篇 |
1971年 | 26篇 |
排序方式: 共有6114条查询结果,搜索用时 15 毫秒
111.
Intestinal Calcium Absorption Decreases Dramatically After Gastric Bypass Surgery Despite Optimization of Vitamin D Status 下载免费PDF全文
Anne L Schafer Connie M Weaver Dennis M Black Amber L Wheeler Hanling Chang Gina V Szefc Lygia Stewart Stanley J Rogers Jonathan T Carter Andrew M Posselt Dolores M Shoback Deborah E Sellmeyer 《Journal of bone and mineral research》2015,30(8):1377-1385
Roux‐en‐Y gastric bypass (RYGB) surgery has negative effects on bone, mediated in part by effects on nutrient absorption. Not only can RYGB result in vitamin D malabsorption, but the bypassed duodenum and proximal jejunum are also the predominant sites of active, transcellular, 1,25(OH)2D‐mediated calcium (Ca) uptake. However, Ca absorption occurs throughout the intestine, and those who undergo RYGB might maintain sufficient Ca absorption, particularly if vitamin D status and Ca intake are robust. We determined the effects of RYGB on intestinal fractional Ca absorption (FCA) while maintaining ample 25OHD levels (goal ≥30 ng/mL) and Ca intake (1200 mg daily) in a prospective cohort of 33 obese adults (BMI 44.7 ± 7.4 kg/m2). FCA was measured preoperatively and 6 months postoperatively with a dual stable isotope method. Other measures included calciotropic hormones, bone turnover markers, and BMD by DXA and QCT. Mean 6‐month weight loss was 32.5 ± 8.4 kg (25.8% ± 5.2% of preoperative weight). FCA decreased from 32.7% ± 14.0% preoperatively to 6.9% ± 3.8% postoperatively (p < 0.0001), despite median (interquartile range) 25OHD levels of 41.0 (33.1 to 48.5) and 36.5 (28.8 to 40.4) ng/mL, respectively. Consistent with the FCA decline, 24‐hour urinary Ca decreased, PTH increased, and 1,25(OH)2D increased (p ≤ 0.02). Bone turnover markers increased markedly, areal BMD decreased at the proximal femur, and volumetric BMD decreased at the spine (p < 0.001). Those with lower postoperative FCA had greater increases in serum CTx (ρ = ?0.43, p = 0.01). Declines in FCA and BMD were not correlated over the 6 months. In conclusion, FCA decreased dramatically after RYGB, even with most 25OHD levels ≥30 ng/mL and with recommended Ca intake. RYGB patients may need high Ca intake to prevent perturbations in Ca homeostasis, although the approach to Ca supplementation needs further study. Decline in FCA could contribute to the decline in BMD after RYGB, and strategies to avoid long‐term skeletal consequences should be investigated. © 2015 American Society for Bone and Mineral Research. 相似文献
112.
Dr. Mary Fanning MD PhD FRCP Marc Monte MD Lloyd R. Sutherland MDCM FRCPC FACP MSc Mary Broadhead RN ONC Gerard F. Murphy MD CM MSc Alan G. Harris MD 《Digestive diseases and sciences》1991,36(4):476-480
Seventeen AIDS patients were enrolled in a prospective open-label dose-finding study of octreotide (Sandostatin) therapy for refractory diarrhea. Five were nonevaluable due to progression of AIDS symptomatology, and one was excluded because of lack of confirmation of HIV infection. Five of 11 evaluable patients responded to therapy (45%); two each at 50 g and 100 g, and one at 250 g thrice daily doses. A sixth patient demonstrated a moderate reduction in stool volume at 250 g thrice daily, which, although deemed clinically relevant, did not meet the criteria for response. On discontinuation of therapy, diarrhea recurred in all patients within 1–12 days, and responded to reinitiation of octreotide in those five patients who resumed treatment. Only one of the three patients with concurrent cryptosporidial infection responded to treatment. The drug was well tolerated, with mild symptomatology in three patients. Long-term treatment at a stable dose was effective in three of five treated patients for periods for seven months in one (moderate responder) and one year in two. One patient required dose increases to control symptoms, but after one year of treatment developed severe nausea following injections, which required dose cessation. One patient had partial control of his diarrhea for only three months despite two dose increases. These data suggest that octreotide may be of useful therapeutic value in HIV-associated diarrhea and that further studies are indicated.This study was supported by Sandoz Canada Inc. 相似文献
113.
Philip J. Swaney Hunter B. Gilbert Robert J. Webster III Paul T. Russell III Kyle D. Weaver 《Skull base》2015,76(2):145-149
Objectives The purpose of this study is to experimentally evaluate the use of concentric tube continuum robots in endonasal skull base tumor removal. This new type of surgical robot offers many advantages over existing straight and rigid surgical tools including added dexterity, the ability to scale movements, and the ability to rotate the end effector while leaving the robot fixed in space. In this study, a concentric tube continuum robot was used to remove simulated pituitary tumors from a skull phantom.
Design The robot was teleoperated by experienced skull base surgeons to remove a phantom pituitary tumor within a skull. Percentage resection was measured by weight. Resection duration was timed.
Setting Academic research laboratory.
Main Outcome Measures Percentage removal of tumor material and procedure duration.
Results Average removal percentage of 79.8 ± 5.9% and average time to complete procedure of 12.5 ± 4.1 minutes (n = 20).
Conclusions The robotic system presented here for use in endonasal skull base surgery shows promise in improving the dexterity, tool motion, and end effector capabilities currently available with straight and rigid tools while remaining an effective tool for resecting the tumor. 相似文献
114.
115.
116.
VL Scarborough NP Dunning KB Tankersley C Carr E Weaver L Grazioso B Lane JG Jones P Buttles F Valdez DL Lentz 《Proceedings of the National Academy of Sciences of the United States of America》2012,109(31):12408-12413
The access to water and the engineered landscapes accommodating its collection and allocation are pivotal issues for assessing sustainability. Recent mapping, sediment coring, and formal excavation at Tikal, Guatemala, have markedly expanded our understanding of ancient Maya water and land use. Among the landscape and engineering feats identified are the largest ancient dam identified in the Maya area of Central America; the posited manner by which reservoir waters were released; construction of a cofferdam for dredging the largest reservoir at Tikal; the presence of ancient springs linked to the initial colonization of Tikal; the use of sand filtration to cleanse water entering reservoirs; a switching station that facilitated seasonal filling and release; and the deepest rock-cut canal segment in the Maya Lowlands. These engineering achievements were integrated into a system that sustained the urban complex through deep time, and they have implications for sustainable construction and use of water management systems in tropical forest settings worldwide. 相似文献
117.
118.
119.
Autumn R. Meek Gordon A. Simms Donald F. Weaver 《Journal of psychiatry & neuroscience : JPN》2013,38(4):269-275
Background
Alzheimer disease is a neurodegenerative disorder that progresses with marked interindividual clinical variability. We postulate the existence of endogenous molecules within the human brain exerting an antiaggregant activity that will prevent/slow Alzheimer disease progression.Methods
We performed in silico studies to determine if the small endogenous molecules L-phosphoserine (L-PS) and 3-hydroxyanthranilic acid (3-HAA) could bind to the target region of β-amyloid responsible for protein misfolding. In vitro assays measured the antiaggregation effect of these molecules at varying concentrations.Results
In silico studies demonstrated that L-PS and 3-HAA, both endogenous brain molecules, were capable of binding to the histidine13–histidine–glutamine–lysine16 (HHQK) region of β-amyloid involved in misfolding: these interactions were energetically favoured. The in vitro assays showed that both L-PS and 3-HAA were capable of inhibiting β-amyloid aggregation in a dose-dependent manner, with 3-HAA being more potent than L-PS.Limitations
Studies were performed in silico and in vitro but not in vivo.Conclusion
We successfully identified 2 endogenous brain molecules, L-PS and 3-HAA, that were capable of binding to the region of β-amyloid that leads to protein misfolding and neurotoxicity. Both L-PS and 3-HAA were able to inhibit β-amyloid aggregation in varying concentrations; levels of these compounds in the brain may impact their effectiveness in slowing/preventing β-amyloid aggregation. 相似文献120.